Despite their heightened risk of sexually transmitted infections, minor adolescents (<18 years old) are often excluded from clinical trials. The results of trials of adults should not be assumed to generalize to minors.
Join Project SOAR for a webinar featuring the latest evidence and insights from implementation science research in Malawi and capacity-strengthening activities with DREAMS implementing partners (IPs) in Botswana, Cote d’Ivoire, Haiti, Namibia, and Rwanda.
As everyone in the field is aware, the NIH conducted an input process last year that concluded with a release of new HIV prevention research priorities that favor long acting, systemic formulations (like vaccines, implants and injectables) and negate the need for short acting, user-controlled, no
The Accelerating Children’s HIV/AIDS Treatment (ACT) Initiative was a public-private partnership that expanded pediatric HIV services in nine sub-Saharan African countries from 2014-2016, providing treatment to more than 560,000 children living with HIV.
Bright and early Wednesday morning, nine speakers and more than 70 participants from international development organizations, donor agencies, and academia gathered at AIDS 2018 to discuss best practices and lessons learned from The Accelerating Children’s HIV/AIDS Treatment (ACT), reflecting how we can sustain and continue to accelerate progress in reaching children and adolescents living with HIV. Participants asked thoughtful questions and engaged in lively discussion with the panel of speakers, including reflection on challenges with case identification and the need for countries to strategically position point of care diagnostics.